Gmeiner P - Search Results

1

Mimicking of Arginine by Functionalized N(ω)-Carbamoylated Arginine As a New Broadly Applicable Approach to Labeled Bioactive Peptides: High Affinity Angiotensin, Neuropeptide Y, Neuropeptide FF, and Neurotensin Receptor Ligands As Examples.

Keller M, Kuhn KK, Einsiedel J, Hübner H, Biselli S, Mollereau C, Wifling D, Svobodová J, Bernhardt G, Cabrele C, Vanderheyden PM, Gmeiner P, Buschauer A. Keller M, et al. Among authors: gmeiner p. J Med Chem. 2016 Mar 10;59(5):1925-45. doi: 10.1021/acs.jmedchem.5b01495. Epub 2016 Feb 11. J Med Chem. 2016. PMID: 26824643

2

Azaindole derivatives with high affinity for the dopamine D4 receptor: synthesis, ligand binding studies and comparison of molecular electrostatic potential maps.

Löber S, Hübner H, Gmeiner P. Löber S, et al. Among authors: gmeiner p. Bioorg Med Chem Lett. 1999 Jan 4;9(1):97-102. doi: 10.1016/s0960-894x(98)00692-1. Bioorg Med Chem Lett. 1999. PMID: 9990464

3

Enantio- and diastereocontrolled dopamine D1, D2, D3 and D4 receptor binding of N-(3-pyrrolidinylmethyl)benzamides synthesized from aspartic acid.

Thomas C, Hübner H, Gmeiner P. Thomas C, et al. Among authors: gmeiner p. Bioorg Med Chem Lett. 1999 Mar 22;9(6):841-6. doi: 10.1016/s0960-894x(99)00086-4. Bioorg Med Chem Lett. 1999. PMID: 10206547

4

2,2-Dicyanovinyl as a nonaromatic aryl bioisostere: synthesis, binding experiments and SAR studies of highly selective dopamine D4 receptor ligands.

Haubmann C, Hübner H, Gmeiner P. Haubmann C, et al. Among authors: gmeiner p. Bioorg Med Chem Lett. 1999 Jul 19;9(14):1969-72. doi: 10.1016/s0960-894x(99)00302-9. Bioorg Med Chem Lett. 1999. PMID: 10450964

5

Piperidinylpyrroles: design, synthesis and binding properties of novel and selective dopamine D4 receptor ligands.

Haubmann C, Hübner H, Gmeiner P. Haubmann C, et al. Among authors: gmeiner p. Bioorg Med Chem Lett. 1999 Nov 1;9(21):3143-6. doi: 10.1016/s0960-894x(99)00540-5. Bioorg Med Chem Lett. 1999. PMID: 10560741

6

Conjugated enynes as nonaromatic catechol bioisosteres: synthesis, binding experiments, and computational studies of novel dopamine receptor agonists recognizing preferentially the D(3) subtype.

Hübner H, Haubmann C, Utz W, Gmeiner P. Hübner H, et al. Among authors: gmeiner p. J Med Chem. 2000 Feb 24;43(4):756-62. doi: 10.1021/jm991098z. J Med Chem. 2000. PMID: 10691700

7

Phenyloxazoles and phenylthiazoles as benzamide bioisosteres: synthesis and dopamine receptor binding profiles.

Einsiedel J, Thomas C, Hübner H, Gmeiner P. Einsiedel J, et al. Among authors: gmeiner p. Bioorg Med Chem Lett. 2000 Sep 4;10(17):2041-4. doi: 10.1016/s0960-894x(00)00405-4. Bioorg Med Chem Lett. 2000. PMID: 10987445

8

Azepino- and diazepinoindoles: synthesis and dopamine receptor binding profiles.

Kraxner J, Hübner H, Gmeiner P. Kraxner J, et al. Among authors: gmeiner p. Arch Pharm (Weinheim). 2000 Sep;333(9):287-92. doi: 10.1002/1521-4184(20009)333:9<287::aid-ardp287>3.0.co;2-r. Arch Pharm (Weinheim). 2000. PMID: 11039184

9

Cyanoindole derivatives as highly selective dopamine D(4) receptor partial agonists: solid-phase synthesis, binding assays, and functional experiments.

Hübner H, Kraxner J, Gmeiner P. Hübner H, et al. Among authors: gmeiner p. J Med Chem. 2000 Nov 16;43(23):4563-9. doi: 10.1021/jm0009989. J Med Chem. 2000. PMID: 11087581

10

Comparative molecular field analysis of dopamine D4 receptor antagonists including 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 113), 3-[4-(4-chlorophenyl)piperazin-1-ylmethyl]-1H-pyrrolo-[2,3-b]pyridine (L-745,870), and clozapine.

Lanig H, Utz W, Gmeiner P. Lanig H, et al. Among authors: gmeiner p. J Med Chem. 2001 Apr 12;44(8):1151-7. doi: 10.1021/jm001055e. J Med Chem. 2001. PMID: 11312915

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

267 results

Search Page